Breaking News
March 24, 2019 - Hidden differences between pathology of CTE and Alzheimer’s disease discovered
March 24, 2019 - Knowing causative genes of osteoporosis may open door to more effective treatments
March 24, 2019 - Toilet-seat based cardiovascular monitoring system getting ready to begin commercialization
March 24, 2019 - New model for intensive care identifies factors that send ill patients to ICU
March 24, 2019 - Recommendations Issued for HSCT in Multiple Myeloma
March 24, 2019 - Deep brain stimulation provides sustained relief for severe depression
March 24, 2019 - “Statistical significance” may soon be a thing of past?
March 24, 2019 - Researchers track effects of epigenetic marks carried by sperm chromosomes
March 24, 2019 - AHA News: Family Adopts Three Children With Three Different Heart Conditions
March 24, 2019 - Research into opioid painkillers could provide clues for safer drug development
March 23, 2019 - Lung cancer survivor recounts her lifetime struggles
March 23, 2019 - Radial and femoral approach for PCI achieve similar results in terms of survival
March 23, 2019 - Study sheds light on the optimal timing of coronary angiography in NSTEMI patients
March 23, 2019 - Excess hormones could cause a condition that can lead to blindness in women, study finds
March 23, 2019 - Dramatic shifts in first-time opioid prescriptions bring hope, concern
March 23, 2019 - Antidepressant drugs may not work when neurons are out of shape
March 23, 2019 - TTUHSC El Paso to establish endowed chair in neurology through a major grant
March 23, 2019 - New device approved by FDA for treating patients with moderate-to-severe heart failure
March 23, 2019 - People with peripheral artery disease have lower Omega-3 Index, shows research
March 23, 2019 - Trigger warnings have minimal impact on how people respond to content, shows research
March 23, 2019 - Gilead Announces Data From Two Studies Supporting Further Development of GS-6207, a Novel, Investigational HIV-1 Capsid Inhibitor as a Component of Future Long-Acting HIV Therapies
March 23, 2019 - Selfish genetic elements amplify inflammation and age-related diseases
March 23, 2019 - Study provides new understanding of how the brain recovers from damage caused by stroke
March 23, 2019 - CRISPR/Cas libraries could revolutionize drug discovery
March 23, 2019 - Allergic reaction during pregnancy may alter sexual-development in offspring’s brain
March 23, 2019 - Seeing through a robot’s eyes helps those with profound motor impairments
March 23, 2019 - Recent research shows that ease of breastfeeding after C-section differs culturally
March 23, 2019 - Newly discovered parameters offer more control over efficient release of drugs
March 23, 2019 - ‘De-tabooing’ of abortion- Women would like more support from health care community
March 23, 2019 - Anti-TB drugs can increase susceptibility to Mtb reinfection
March 23, 2019 - New survey indicates need of attention to neglected tropical diseases
March 23, 2019 - Innovative in vitro method to develop easy-to-swallow medicine for children and older people
March 23, 2019 - Sugary drinks could raise risk of early deaths finds study
March 23, 2019 - Lian wins ENGINE grant for stem-cell-based therapy to treat Type 1 diabetes
March 23, 2019 - Overall, Physicians Are Happy and Enjoy Their Lives
March 23, 2019 - Researchers discover how blood vessels protect the brain during inflammation
March 23, 2019 - CDC study shows modest improvement in optimal hospital breastfeeding policy
March 23, 2019 - Family-based prevention program to reduce alcohol use among older teens
March 23, 2019 - Remote monitoring of implanted defibrillators in heart failure patients prevents hospitalizations
March 23, 2019 - Appropriate doffing of personal protective equipment may reduce healthcare worker contamination
March 23, 2019 - Window screens can suppress mosquito populations, reduce malaria in Tanzania
March 23, 2019 - Researchers discover new biomarker for postoperative liver dysfunction
March 23, 2019 - Pregnancy history may be linked to cognitive function in older women, finds study
March 23, 2019 - Study shows ticagrelor is equally safe and effective as clopidogrel after heart attack
March 23, 2019 - FDA Approves First Drug for Postpartum Depression, Zulresso (brexanolone)
March 23, 2019 - New guidelines outline new treatment management for psoriasis
March 23, 2019 - Thermally abused cooking oil may promote progression of breast cancer
March 23, 2019 - High-fructose corn syrup fuels growth of colon tumors in mice
March 23, 2019 - Partnership aims at establishing best practices to promote diversity in clinical trials
March 23, 2019 - New study examines presence of microbes in tap water from residences, office buildings
March 23, 2019 - Early life trauma may affect brain structure, contribute to major depressive disorder
March 23, 2019 - NIH starts clinical trial of drug to treat cravings associated with opioid use disorder
March 23, 2019 - Cervix bacteria, immune factors could be a warning signal of premature birth, reports new research
March 23, 2019 - Worst-ever emergency care performance figures underscore the need to focus on staffing
March 23, 2019 - The Current issue of “The view from here” is concerned with Cancer
March 23, 2019 - Mouse model validates how ‘good’ and ‘bad’ bacteria affect acne
March 23, 2019 - Individual amygdala neurons respond to touch, imagery and sounds
March 23, 2019 - Combination of two topical creams can prevent cancer
March 23, 2019 - Study suggests depression screening when assessing African-Americans for schizophrenia
March 23, 2019 - New electronic support system for choosing drug treatment based on patient’s genotype
March 23, 2019 - First-of-its-kind study provides pregnancy statistics of imprisoned U.S. women
March 23, 2019 - Marinus Pharmaceuticals Initiates Phase 3 Study in Children with PCDH19-Related Epilepsy
March 23, 2019 - Laparoscopy: MedlinePlus Lab Test Information
March 23, 2019 - Shellfish allergies: can they be treated?
March 23, 2019 - Toilet seat heart monitoring system
March 23, 2019 - Researchers identify way to improve common treatment for PTSD
March 23, 2019 - High potency cannabis use linked to psychosis finds study
March 23, 2019 - Evoke Pharma Submits Response to FDA Review Letter for Gimoti NDA
March 23, 2019 - Tracking HIV’s ever-evolving genome in effort to prioritize public health resources
March 23, 2019 - Scientists grow most sophisticated brain organoid to date
March 23, 2019 - ADHD drug raising risk of psychosis
March 22, 2019 - FDA approves brexanolone, first drug developed to treat postpartum depression
March 22, 2019 - Gruesome cat and dog experiments by the USDA exposed
March 22, 2019 - Ball pits used in children’s physical therapy may contribute to germ transmission
March 22, 2019 - Long-term use of inexpensive weight-loss drug may be safe and effective
March 22, 2019 - FDA Approves Sunosi (solriamfetol) for Excessive Daytime Sleepiness Associated with Narcolepsy or Obstructive Sleep Apnea
March 22, 2019 - Anti-Müllerian Hormone Test: MedlinePlus Lab Test Information
March 22, 2019 - Finding the right exercise, diet aids for HIV patients
March 22, 2019 - Health Plans For State Employees Use Medicare’s Hammer On Hospital Bills
March 22, 2019 - Researchers develop new tool for imaging large groups of neurons in living animals
New molecular switch may help develop sophisticated photomedications

New molecular switch may help develop sophisticated photomedications

image_pdfDownload PDFimage_print

Light-activated switches are too small to be seen by the naked eye, but the molecular systems are hard at work in research related to drug design, adaptive materials and data storage. To unlock the promise of new generations of medical therapies and memory systems, researchers must first overcome the drawbacks of the microscopic devices that can be difficult to produce and lack versatility.

Researchers at Dartmouth College have developed a new molecular switch based on the hydrazone functional group that combines the most important properties of the current class of light-activated switches and solves many of the problems associated with them. The newly-developed molecule is easy to make, simple to work with, shows “on-off” fluorescence emission toggling, and can be used to write, read and erase information in both the liquid and solid state.

Looking into the future, switches like these may potentially be used for the development of sophisticated photomedications that deliver drugs with cellular-level precision. In years to come, hydrazone switches might also lead to the development of high-density memory devices with the volume of a speck of a dust.

As detailed in the Journal of the American Chemical Society, Dartmouth’s hydrazone system, “packs most, if not all, the desired, targeted and sought-after traits from photochromic compounds.”

“This is a switch that can do it all,” said Ivan Aprahamian, an associate professor of chemistry and head of the research team at Dartmouth. “What we developed is a new tool that combines all the good properties of known switches without their side effects, and in a simple, straight-forward design.”

Similar to flipping a physical switch, photochromic switches rely on lights of different wavelengths to move molecules between the “on” and “off” positions. The fluorescent feedback produced during the switching process can be used to store and read huge amounts of data at microscopic scale and even provide signals about where a medication is being delivered after the drug enters into a patient’s body, an important tool for drug targeting.

To toggle the switch in the Dartmouth study, researchers used a “blue light” operating at the same 450 nm wavelength of a laser pointer to write the information by activating the switch. A second 365 nm ultraviolet wavelength was used to erase the information by turning the switch off.

In the paper, the researchers demonstrated that the switch works in both water and fetal bovine serum buffer–a frequently used bio-medium–confirming that the molecular system can be useful as a drug delivery tool.

In addition to performing well in solution, the researchers found that the hydrazone switch also works on solid-state films. Molecules that go through large structural changes usually do not operate in solid state without complex manipulation. This added functionality allows it to be used effectively for data storage.

“Such an on-off fluorescence response in both solution and solid state for photochromic compounds is highly unusual,” said Baihao Shao, a PhD student at Dartmouth and the first author of the study.

The team was able to use both single-photon and two-photon light sources to operate the new switch. The near infrared, two-photon system allows the light to penetrate tissue deeper and makes it safer for use with humans. Two-photon activation also allows for 3D microscopy techniques that are important for advanced data storage.

The research paper notes that the hydrazone switch has a half-life of 75 years in solution at room temperature. In solid state, the switch’s memory could be indefinite. Such stability is another key feature that adds to its overall functionality for long-term data storage.

“We are extremely excited by the results as well as the reception it is getting from the scientific community. Based on these and yet unpublished results, we feel that this technology has the promise to be truly transformative,” said Aprahamian.

During the experiment, some erasure did occur during reading as the excitation light also results in slow switching, creating a challenge that the researchers are working to minimize.

Source:

https://news.dartmouth.edu/

Tagged with:

About author

Related Articles